Podolife

Podolife is the specialized podiatry division of Epitech Group, an Italian pharmaceutical company focused on the development of pharmacological solutions for foot and nail pathologies. The company utilizes the proprietary ALIA (Autacoid Local Injury Antagonism) technology, which leverages endogenous lipids like Palmitoylethanolamide (PEA) and its analogues to modulate mast cell hyperactivity and neuroinflammation. Podolife's product portfolio includes advanced topical treatments for complex conditions such as diabetic foot syndrome, as well as common podiatric issues like hyperkeratosis and nail dystrophies. By integrating dermatology, neurology, and vascular medicine, Podolife provides a comprehensive approach to the treatment of the foot as a complex organ system.